Please login to the form below

Not currently logged in
Email:
Password:

malaria

This page shows the latest malaria news and features for those working in and with pharma, biotech and healthcare.

Evotec says Sanofi deal makes it anti-infectives powerhouse

Evotec says Sanofi deal makes it anti-infectives powerhouse

regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.” It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,

Latest news

More from news
Approximately 17 fully matching, plus 94 partially matching documents found.

Latest Intelligence

  • Waking the sleeping giant Waking the sleeping giant

    In Uganda, a malaria-specific app provides questions and answers relating to that disease, while in Mozambique another app greatly increases the efficacy of immunisation programmes by reminding users via text

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    developing a device that can detect malaria and give you a result in two minutes.

  • Aiming high for women Aiming high for women

    6. Halt and start to reverse the spread and incidence of HIV/AIDS, malaria and other diseases - MISSED, although the number of new HIV/AIDS infections fell by 40% in

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio

  • Amazing Africa Amazing Africa

    HIV/AIDS, malaria, famine, Ebola: there is a reason why the World Health Organization (WHO) considers it to be the region confronting the most dramatic public health crisis across the globe.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Former PEPFAR head Mark Dybul to lead the Global Fund Former PEPFAR head Mark Dybul to lead the Global Fund

    Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark Dybul as executive director.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics